and decreases at the same rate as the change in revenue. In terms of the profit of the Company for Q1–2021 changed in line with the change in revenue, when compare to Q4–2020 and Q1–2020. Compare to the
in Q1-2023. Total operating expenses in Q2-2023 have changed in the same direction and at a similar rate with the increase and decrease in revenue when compared to Q1- 2023 and Q2- 2022. However, the
operating expenses in Q1–2024 changed in line with and similar to the increase or decrease in revenue compared to Q1–2023. That is to say, the change rate in revenue for Q1–2024 increased by 29.9% and the
in Q3–2024 have changed in line with the same direction, and the rate is also similar to the increase and decrease in revenue. When compared to the increase rate in the total operating expenses in Q3
Enhanced86 Not for Retail Investors (11) 19 “ ” (12) (13) 22 “ ” (14) . . . (15) . . . (16) 6 . . . . . . . . . (17) (18) (19) . . . 3 / (20) . . . 5 (21) . . . 60 (auto redemption) (22) . . . 2 “ ” . . . (23
establishment of mutual funds, covered management companies shall submit an application in the normal course similar to an application for establishment of ASEAN CIS and ARFP, for which an auto approval is not
mainly from auto part tooling revenue recognition and packaging for milk and milk yogurt. For business in China, Sales of Tianjin plant decreased from the closure of the factory at the beginning of the
เซอร์วิส จำกัด (มหาชน) AIT: ADVANCED INFORMATION TECHNOLOGY PUBLIC CO.,LTD. AJA: AJ ADVANCE TECHNOLOGY PUBLIC COMPANY LIMITED ASAP: SYNERGETIC AUTO PERFORMANCE PUBLIC COMPANY LIMITED BIS: Bioscience Animal
COMPANY LIMITED AIT: ADVANCED INFORMATION TECHNOLOGY PUBLIC CO.,LTD. AJA: AJ ADVANCE TECHNOLOGY PUBLIC COMPANY LIMITED ASAP: SYNERGETIC AUTO PERFORMANCE PUBLIC COMPANY LIMITED BIS: Bioscience Animal Health
management companies shall submit an application in the normal course similar to an application for establishment of ASEAN CIS and ARFP, for which an auto approval is not allowed. For your information and